NCT02851914View on ClinicalTrials.gov

SSRIs vs. TCAs for Depression in ALS Patients

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

July 21, 2015

Primary Completion Date

May 30, 2019

Study Completion Date

May 30, 2019

Conditions
DepressionAmyotrophic Lateral Sclerosis
Interventions
DRUG

"Tricyclic Antidepressants (TCA)"

if patient shows signs of depression they will be placed on one of these medications and seen by a psychiatrist.

DRUG

"Selective Serotonin Uptake Inhibitors (SSRI)"

if patient shows signs of depression they will be placed on one of these medications and seen by a psychiatrist.

Trial Locations (1)

63104

Monteleone Hall, Saint Louis University, 1438 South Grand Blvd., St Louis

All Listed Sponsors
lead

St. Louis University

OTHER

NCT02851914 - SSRIs vs. TCAs for Depression in ALS Patients | Biotech Hunter | Biotech Hunter